Projects per year
Personal profile
Personal Statement
Alex is a registered pharmacist who obtained a BSc (Hons) in Pharmacy and a PhD in Drug Delivery from the University of Strathclyde.
Prior to his appointment as a lecturer in 1999, Alex had previously worked in the pharmaceutical industry (Reckitt Benckiser) and as a post-doctoral research fellow in the Department of Immunology, University of Strathclyde, on a WHO-financed project involving the pre-clinical development of parenteral liposomal delivery systems for infectious diseases.
Since his appointment, Alex has developed an extensive research portfolio, encompassing oral and vesicular drug delivery technologies, drug eluting stents, liposomes, vaginal and vaccine delivery systems.
In 2008 Alex was appointed Professor of Pharmacy Practice and has used this science-based practice chair to develop cross disciplinary research integrating and bridging science and practice elements of the pharmacy profession to widen patient access to better medicines and to realise better use of medicines.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, University of Strathclyde
Award Date: 1 Jan 1998
Bachelor of Pharmacy, University of Strathclyde
Award Date: 1 Jan 1990
Fingerprint
Dive into the research topics where Alexander Mullen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Glasgow Science Festival SIPBS Open doors day 2025
Boyd, M. (Principal Investigator) & Mullen, A. (Principal Investigator)
14/06/25 → …
Project: Knowledge Exchange
-
Novel combination therapies for ovarian ancer
Boyd, M. (CoPI) & Mullen, A. (CoPI)
1/10/24 → …
Project: Research
-
Factors associated with prescribing initial antidiabetic drugs among patients with type 2 diabetes mellitus in Scotland, 2010 – 2020: a retrospective population-based study
Mohammad, F., Mueller, T., Mullen, A., Sainsbury, C., Rushworth, G. F. & Kurdi, A., 7 May 2025, In: Journal of Pharmaceutical Policy and Practice. 18, S2, p. 135-136 2 p., 207.Research output: Contribution to journal › Conference abstract › peer-review
Open Access -
Solvent-free microfluidic fabrication of antimicrobial lipid nanoparticles
Ruano-Aldea, M., Sut, T. N., Tan, S. W., Mullen, A., Kelemen, D., Ferro, V. A. & Jackman, J., 17 Mar 2025, In: ACS Applied Bio Materials. 8, 3, p. 2194-2203 10 p.Research output: Contribution to journal › Article › peer-review
Datasets
-
Data for: "Sepsis scoring systems and use of the Sepsis six care bundle in maternity hospitals"
Abutheraa, N. (Creator), Grant, J. (Creator) & Mullen, A. B. (Creator), figshare, 16 Mar 2023
DOI: 10.6084/m9.figshare.c.5526864.v1
Dataset
Activities
-
Latium Research Limited (External organisation)
Boyd, M. (Advisor) & Mullen, A. (Advisor)
2025 → …Activity: Membership types › Membership of committee
-
CBTDDC conference Edinburgh 2020
Boyd, M. (Speaker) & Mullen, A. (Speaker)
Feb 2020Activity: Talk or presentation types › Invited talk
Impacts
-
Economic benefit and competitive advantage from commercial adoption of an innovative non-invasive delivery method for drugs and vaccines
Carter, K. (Participant), Ferro, V. (Participant), Mullen, A. (Participant) & Alexander, J. (Participant)
Impact: Impact - for External Portal › Economic and commerce, Health and welfare - new products, guidelines and services
File